Funding for this research was provided by:
National Institutes of Health (R01CA170357, R01CA179243)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK084567)
Center for Individualized Medicine, Mayo Clinic
Randy Shaver Cancer Research and Community Fund
Alfred P. Sloan Foundation
Mayo Clinic Metabolomics Resource Core (U24DK100469)
Fred C. Anderson Foundation
Minnesota Partnership for Biotechnology and Medical Genomics
National Institute of Genomic Medicine
Received: 13 June 2018
Accepted: 8 October 2018
First Online: 31 October 2018
Ethics approval and consent to participate
: This study was performed with the approval of the Mayo Clinic Institutional Review Board (IRB# 14-007237 and IRB# 622-00) in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all individuals in the study.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.